Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Women's Health and Genetics/Laboratory Corporation of America, |
RCV001193612 | SCV001362560 | pathogenic | Peroxisome biogenesis disorder | 2021-03-14 | criteria provided, single submitter | clinical testing | Variant summary: PEX1 c.3180dupT (p.Gly1061TrpfsX16) results in a premature termination codon, predicted to cause a truncation of the encoded protein or absence of the protein due to nonsense mediated decay, which are commonly known mechanisms for disease. Truncations downstream of this position have been been reported in patients with Zellweger syndrome (HGMD database). The variant was absent in 251100 control chromosomes. c.3180dupT has been reported in the literature in individuals affected with Zellweger Syndrome and subsequently cited by others (example, Collins_1999, Rosewich_2005). No clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014. Based on the evidence outlined above, the variant was classified as pathogenic. |
Labcorp Genetics |
RCV001380781 | SCV001578943 | pathogenic | Zellweger spectrum disorders | 2024-01-24 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Gly1061Trpfs*16) in the PEX1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in PEX1 are known to be pathogenic (PMID: 21031596, 26387595, 31831025). This variant is not present in population databases (gnomAD no frequency). This premature translational stop signal has been observed in individual(s) with Zellweger syndrome spectrum (PMID: 10447258). ClinVar contains an entry for this variant (Variation ID: 928943). For these reasons, this variant has been classified as Pathogenic. |
Baylor Genetics | RCV003473733 | SCV004203337 | pathogenic | Heimler syndrome 1 | 2023-06-06 | criteria provided, single submitter | clinical testing | |
Department of Pathology and Laboratory Medicine, |
RCV001193612 | SCV005913835 | pathogenic | Peroxisome biogenesis disorder | 2023-07-15 | criteria provided, single submitter | research |